日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A STAT3 degrader demonstrates efficacy in venetoclax resistant acute myeloid leukemia

STAT3降解剂在维奈托克耐药的急性髓系白血病中显示出疗效

Chakraborty, Samarpana; Morganti, Claudia; Zaldana, Kimberly; Rivera Pena, Bianca; Zhang, Hui; Verma, Divij; Gitego, Nadege; Ma, Feiyang; Aluri, Srinivas; Pradhan, Kith; Gordon-Mitchell, Shanisha; Mantzaris, Ioannis; Goldfinger, Mendel; Feldman, Eric; Gritsman, Kira; Shi, Yang; Hubner, Stefan; Qiu, Yi Hua; Brown, Brandon D; Khasawneh, Abdullah; Skwarska, Anna; de Camargo Magalhães, Eduardo Sabino; Verma, Amit; Konopleva, Marina; Tabe, Yoko; Gavathiotis, Evripidis; Colla, Simona; Gollob, Jared; Dey, Joyoti; Kornblau, Steven M; Koralov, Sergei B; Ito, Keisuke; Shastri, Aditi

Metronomic low-dose regimen of decitabine and venetoclax is safe and reduces monocyte burden in chronic myelomonocytic leukemia

地西他滨和维奈托克的节拍式低剂量方案安全有效,并能降低慢性粒单核细胞白血病中的单核细胞负荷。

Rockwell, Bradley; Goldfinger, Mendel; Mantzaris, Ioannis; Shastri, Aditi; Saunthararajah, Yogen; Gritsman, Kira; Sica, Alejandro R; Kornblum, Noah; Shah, Nishi; Levitz, David; Shapiro, Lauren C; Gupta, Ridhi; Munoz, Anne; Dhawan, Aradhika; Fehn, Karen; Comas, Monica; Verceles, Jhannine; Cooper, Dennis L; Konopleva, Marina; Feldman, Eric J; Verma, Amit

A phase I, single-arm, open-label, dose-escalation, multicenter study of SAR445419, an off-the-shelf, ex vivo expanded allogeneic natural killer cell product, in participants with relapsed or refractory acute myeloid leukemia

一项针对复发或难治性急性髓系白血病患者的 I 期、单臂、开放标签、剂量递增、多中心研究,旨在评估 SAR445419(一种现成的、体外扩增的异基因自然杀伤细胞产品)的疗效。

Konopleva, Marina; Bhatt, Vijaya Raj; Mantzaris, Ioannis; Maiti, Abhishek; Gundabolu, Krishna; Schafer, Jolie; Jensen, Kyle; Saleem, Rao; Li, Yi; Drewniak, Agata; Bay, Pierre; Huh, Winston; Yildirim, Ozlem; Abbadessa, Giovanni; Cooley, Sarah; Daver, Naval

Financial Toxicity of Hematologic Malignancy Therapies, Including Cellular Therapy and Its Impact on Access to Care: Prospective Pilot Study

血液系统恶性肿瘤疗法(包括细胞疗法)的经济毒性及其对医疗服务可及性的影响:前瞻性试点研究

Amaeshi, Lemchukwu; Laufer, Lauren; Fedorov, Kateryna; Sisto, Alex; Levitz, David; Mathew, Rosmi; Wright, Karen; Cooper, Dennis; Goldfinger, Mendel; Mantzaris, Ioannis; Sica, R Alejandro; Gritsman, Kira; Konopleva, Marina; Gupta, Ridhi; Kornblum, Noah; Zhang, Chenxin; Kim, Mimi; Verma, Amit; Rapkin, Bruce; Shastri, Aditi; Shah, Nishi

Menin Inhibition With Revumenib for KMT2A-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101)

Revumenib 抑制 Menin 治疗 KMT2A 重排复发或难治性急性白血病 (AUGMENT-101)

Issa, Ghayas C; Aldoss, Ibrahim; Thirman, Michael J; DiPersio, John; Arellano, Martha; Blachly, James S; Mannis, Gabriel N; Perl, Alexander; Dickens, David S; McMahon, Christine M; Traer, Elie; Zwaan, C Michel; Grove, Carolyn S; Stone, Richard; Shami, Paul J; Mantzaris, Ioannis; Greenwood, Matthew; Shukla, Neerav; Cuglievan, Branko; Kovacsovics, Tibor; Gu, Yu; Bagley, Rebecca G; Madigan, Kate; Chudnovsky, Yakov; Nguyen, Huy Van; McNeer, Nicole; Stein, Eytan M

Venetoclax plus daunorubicin and cytarabine for newly diagnosed acute myeloid leukemia: results of a phase 1b study

维奈托克联合柔红霉素和阿糖胞苷治疗新诊断的急性髓系白血病:一项 1b 期研究的结果

Mantzaris, Ioannis; Goldfinger, Mendel; Uriel, Matan; Shastri, Aditi; Shah, Nishi; Gritsman, Kira; Kornblum, Noah S; Shapiro, Lauren; Sica, Roberto Alejandro; Munoz, Anne; Chambers, Nicole; Dhawan, Aradhika; Verceles, Jhannine Alyssa; Fehn, Karen; Tirone, Balda; Shah, Lamisha; Clark, Shaunmonique; Zhang, Chenxin; Kim, Mimi; Cooper, Dennis L; Verma, Amit; Konopleva, Marina; Feldman, Eric J

Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study

使用revumenib抑制Menin治疗NPM1突变复发或难治性急性髓系白血病:AUGMENT-101研究

Arellano, Martha L; Thirman, Michael J; DiPersio, John F; Heiblig, Maël; Stein, Eytan M; Schuh, Andre C; Žučenka, Andrius; de Botton, Stephane; Grove, Carolyn S; Mannis, Gabriel N; Papayannidis, Cristina; Perl, Alexander E; Issa, Ghayas C; Aldoss, Ibrahim; Bajel, Ashish; Dickens, David S; Kühn, Michael W M; Mantzaris, Ioannis; Raffoux, Emmanuel; Traer, Elie; Amitai, Irina; Döhner, Hartmut; Greco, Corinna; Kovacsovics, Tibor; McMahon, Christine M; Montesinos, Pau; Pigneux, Arnaud; Shami, Paul J; Stone, Richard M; Wolach, Ofir; Harpel, John G; Chudnovsky, Yakov; Yu, Li; Bagley, Rebecca G; Smith, Angela R; Blachly, James S

Assessing the performance of the Iceland screens, treats, or prevents multiple myeloma (iStopMM) model in a multicultural Bronx cohort: implications for monoclonal gammopathy of undetermined significance risk stratification

评估冰岛筛查、治疗或预防多发性骨髓瘤(iStopMM)模型在布朗克斯多元文化队列中的表现:对意义未明的单克隆丙种球蛋白病风险分层的启示

Gor, Rajvi; Shivakumar, Jeevan; Surana, Pallavi; Wei, John; Murakhovskaya, Irina; Goldfinger, Mendel; Kornblum, Noah; Shapiro, Lauren; Shastri, Aditi; Gupta, Ridhi; Levitz, David; Konopleva, Marina; Feldman, Eric; Gritsman, Kira; Sica, R Alejandro; Mantzaris, Ioannis; Verma, Amit; Cooper, Dennis; Janakiram, Murali; Shah, Nishi

A germline FLT3 variant in aplastic anemia

再生障碍性贫血中的种系FLT3变异

Amaeshi, Lemchukwu C; Sofianidi, Amalia A; Shastri, Aditi; Goldfinger, Mendel; Konopleva, Marina; Verma, Amit K; Chaitowitz, Mark; Mantzaris, Ioannis

CNS Involvement by North American-Adult T-cell Leukemia/Lymphoma Is Associated With Discrete Dissemination Patterns and Molecular Profiles, Involving XPO1 E571 and KLF2/PI3KCD in Selected Cases

北美成人T细胞白血病/淋巴瘤累及中枢神经系统与不同的播散模式和分子特征相关,在某些病例中涉及XPO1 E571和KLF2/PI3KCD。

Shah, Nishi; Suchanek, Melissa; Thakkar, Astha; Patel, Riya Jayesh; Rahman, Shafia; Acuna-Villaorduna, Ana; Shah, Urvi; Adrianzen Herrera, Diego; Slasky, Shira; Gritsman, Kira; Goldfinger, Mendel; Shastri, Aditi; Mantzaris, Ioannis; Kornblum, Noah; Bachier-Rodriguez, Lizamarie; Feldman, Eric; Cooper, Dennis; McNeill, Katharine Anne; Wang, Yanhua; Shi, Yang; Verma, Amit; Ye, B Hilda; Janakiram, Murali; Sica, R Alejandro